Brief: Mei Pharma Adopts Limited-Duration Stockholder Rights Plan
02/10/2023 15:48
Oct 2 (Reuters) - MEI Pharma Inc MEIP.O :
* MEI PHARMA ADOPTS LIMITED-DURATION STOCKHOLDER RIGHTS PLAN
* MEI PHARMA INC - RIGHTS WILL BECOME EXERCISABLE ONLY IF
ANY
PERSON ACQUIRES 20% OR MORE OF COMPANY'S OUTSTANDING COMMON
STOCK
* MEI PHARMA INC: BOARD UNANIMOUSLY APPROVED ADOPTION OF A
LIMITED-DURATION STOCKHOLDER RIGHTS PLAN
* MEI PHARMA INC: BOARD RESOLVED TO ADOPT RIGHTS PLAN
FOLLOWING
RECENT SCHEDULE 13D AMENDMENTS FILED BY ANSON ADVISORS AND CABLE
CAR CAPITAL
* MEI PHARMA INC: PURSUANT TO RIGHTS PLAN, CO IS ISSUING ONE
RIGHT
FOR EACH SHARE OF COMMON STOCK AS OF CLOSE OF BUSINESS ON
OCTOBER 12
Source text for Eikon: ID:nBw9K1JvDa
Further company coverage: MEIP.O
((Reuters.Briefs@thomsonreuters.com
))
Recent news on Lite Strategy
See all newsBrief: Lite Strategy Receives Governance Rights And Option To Buy Litvm Future Network Tokens
U.S. RESEARCH ROUNDUP- Equinix, KLA, WW Grainger
Brief: Lite Strategy Inc - On Nov 14, Board Approves Justin J. File As Permanent CEO - SEC Filing
Brief: Lite Strategy Reports First Quarter Fiscal Year 2026 Results Highlights Successful Launch Of $100M Litecoin Treasury Strategy And Movement Into Active Capital Market Operations
Brief: Lite Strategy Announces $25M Share Repurchase Program, Signaling Shift From Initial Litecoin Accumulation To Active Capital Market Operations